Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lexagene Holdings Inc V.LXG


Primary Symbol: LXXGQ

Healthcare Medical Devices
Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.


GREY:LXXGQ - Post by User

Lexagene Holdings Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(159)
•••
Post by TanzaniteMotherLodeon Sep 16, 2021 9:25am
113 Views
Post# 33867728

BIOTHREAT NEWS WITH US ARMY

BIOTHREAT NEWS WITH US ARMYThat is big. 15 years ago I was involved with DOD on biothreat fast detection, with something much faster than cultures but not as fast as LexaGene. Big money can be behind this. The urgency I saw was amazing, cold called the head of bioterror defense, think he was 2 star general and he put me in contact with head of procurement within 10 mins! Via Blackberry, remember it clearly. Great news and makes them more appealing to buy out.

The above from another chat line CEO.CA

......This CRADA aims to foster innovative biothreat defense capability development, which is part of DEVCOM’s current technology priorities. LexaGene will work with the United States Army to demonstrate the capabilities of the MiQLabTM, LexaGene’s flagship pathogen detection system......

https://ca.finance.yahoo.com/news/lexagene-enters-cooperative-research-development-114500038.html


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities